Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study

We developed prediction rules to guide the clinical diagnosis of Alzheimer’s disease (AD) in two community-based cohort studies (the Religious Orders Study and the Rush Memory and Aging Project). The rules were implemented without informant interviews, neuroimaging, blood work or routine case conferencing. Autopsies were performed at death and the pathologic diagnosis of AD made with a modified version of the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) criteria. We compared the positive predictive value of the clinical diagnosis in the two community-based studies to the positive predictive value of the clinical diagnosis of AD made by standard clinical practice in a clinic-based cohort study using AD pathology as the gold standard. Of 306 clinic cases with probable AD, 286 (93.5%) met CERAD neuropathologic criteria for AD; the results were comparable for those with possible AD (51 of 54, 94.4%). Of 141 study subjects with probable AD, 130 (92.2%) met CERAD neuropathologic criteria for AD; the results were lower but acceptable for those with possible AD (26 of 37, 70.3%). The results were similar in secondary analyses using alternate neuropathologic criteria for AD. The clinical diagnosis of AD can be made in community-based studies without the use of informant interviews, neuroimaging, blood work or routine case conferencing. This approach holds promise for reducing the operational costs of epidemiologic studies of aging and AD.

[1]  Jeffrey L. Cummings,et al.  Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[2]  D. Bennett,et al.  Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale , 1997, Neurology.

[3]  D. Bennett,et al.  Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. , 2000, Psychology and aging.

[4]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[5]  D. Bennett,et al.  Change in Cognitive Function in Alzheimer’s Disease in African-American and White Persons , 2005, Neuroepidemiology.

[6]  D. Bennett,et al.  Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. , 2006, Neurology.

[7]  D. A. Bennett,et al.  Memory complaints are related to Alzheimer disease pathology in older persons , 2006, Neurology.

[8]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[9]  D A Bennett,et al.  Rate of cognitive decline and mortality in Alzheimer’s disease , 2003, Neurology.

[10]  J. Schneider,et al.  Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.

[11]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[12]  W. Jagust,et al.  Neuropathologic Substrates of Ischemic Vascular Dementia , 2000, Journal of neuropathology and experimental neurology.

[13]  H. Chui,et al.  Multicenter clinicopathological correlation in dementia. , 1995, The American journal of psychiatry.

[14]  J. Schneider,et al.  Individual differences in rates of change in cognitive abilities of older persons. , 2002, Psychology and aging.

[15]  David A. Bennett,et al.  The Rush Memory and Aging Project: Study Design and Baseline Characteristics of the Study Cohort , 2005, Neuroepidemiology.

[16]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[17]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[18]  R. Petersen.  Mild cognitive impairment: where are we? , 2005, Alzheimer disease and associated disorders.

[19]  R. Wilson,et al.  The Apolipoprotein E &egr;4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons , 2005 .

[20]  W. Kukull,et al.  The validity of 3 clinical diagnostic criteria for Alzheimer's disease , 1990, Neurology.

[21]  K. Jellinger.  Neuropathologic substrates of ischemic vascular dementia. , 2001, Journal of neuropathology and experimental neurology.

[22]  R. Abbott,et al.  Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. , 1997, JAMA.

[23]  A. Laupacis,et al.  Clinical prediction rules. A review and suggested modifications of methodological standards. , 1997, JAMA.

[24]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[25]  D. Mash,et al.  Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. , 1998, Journal of neuropathology and experimental neurology.

[26]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[27]  B. Miller,et al.  CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[28]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[29]  K. Jellinger,et al.  Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. , 2002, Neurology.

[30]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[31]  W. Markesbery,et al.  AD lesions and infarcts in demented and non‐demented Japanese‐American men , 2005, Annals of neurology.

[32]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[33]  V. Buckles,et al.  Accuracy of Collateral Source Reports in Very Mild to Mild Dementia of the Alzheimer Type , 2003, Journal of the American Geriatrics Society.

[34]  Bruce L. Miller,et al.  Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology , 2007 .

[35]  K. Jellinger,et al.  Postmortem Examination of Vascular Lesions in Cognitive Impairment: A Survey Among Neuropathological Services , 2006, Stroke.

[36]  J. Morris,et al.  Validation of clinical diagnostic criteria for Alzheimer's disease , 1988, Annals of neurology.

[37]  L A Hansen,et al.  Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.

[38]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[39]  A. Evans,et al.  Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions , 2006, Annals of Internal Medicine.

[40]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[41]  David S Knopman,et al.  Vascular dementia in a population-based autopsy study. , 2003, Archives of neurology.

[42]  David C. Steffens,et al.  Comparison of clinical and neuropathologic diagnoses of Alzheimer’s disease in 3 epidemiologic samples , 2006, Alzheimer's & Dementia.

[43]  D. Bennett,et al.  Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[45]  L. Robins,et al.  Validity of the Diagnostic Interview Schedule, Version II: DSM-III diagnoses , 1982, Psychological Medicine.

[46]  C. Lyketsos,et al.  Classification of vascular dementia in the Cardiovascular Health Study Cognition Study , 2005, Neurology.

[47]  D. Brooks,et al.  Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.

[48]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[49]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[50]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[51]  D. Bennett,et al.  Assessment of Cognitive Decline in Old Age with Brief Tests Amenable to Telephone Administration , 2005, Neuroepidemiology.

[52]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.

[53]  J. Morris,et al.  Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. , 2005, Archives of neurology.

[54]  R. Katzman.,et al.  Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.

[55]  Linda Teri,et al.  Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.

[56]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[57]  Benoit Mulsant,et al.  Detection and Management of Cognitive Impairment in Primary Care: The Steel Valley Seniors Survey , 2004, Journal of the American Geriatrics Society.

[58]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[59]  R. Mayeux,et al.  A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. , 1999, Archives of neurology.